FESS术后加用香菊胶囊与康复新液治疗慢性鼻窦炎伴有鼻息肉的对比研究

doi:10.6040/j.issn.1673-3770.0.2020.217

摘要/Abstract

摘要： 目的评价对比慢性鼻窦炎伴有鼻息肉患者功能性鼻内镜手术后,分别加用香菊胶囊口服治疗与康复新液冲洗术腔治疗的有效性及安全性。方法选取择期行FESS治疗的90例CRSwNP患者,使用简单随机数字表法将其随机分成康复新组(n=30)、香菊组(n=30)、对照组(n=30)。所有患者均接受FESS及相同的术后常规处理。对照组在此基础上于FESS术后采取布地奈德鼻喷雾剂喷鼻治疗,香菊组在对照组基础上于FESS术后口服香菊胶囊治疗,康复新组在对照组基础上于FESS术后予以康复新液冲洗术腔,疗程均为12周。比较三组临床疗效、术后术腔黏膜转归情况、不良反应发生情况及随访复发情况。观察手术前后三组主观症状视觉模拟量表(VAS)评分和血清炎症因子［超敏C-反应蛋白(hs-CRP)、肿瘤坏死因子(TNF)-α、白介素(IL)-6和IL-10］水平变化,并进行统计分析。结果康复新组［96.7%(29/30)］、香菊组［93.3%(28/30)］和对照组［86.7%(26/30)］在总有效率上对比差异均无统计学意义(P>0.05)。随访12个月,康复新组和香菊组各失访1例,对照组失访2例。康复新组和香菊组的术后1年复发率分别为13.8%(4/29)、17.2%(5/29),低于对照组［28.6%(8/28)］,但差异均无统计学意义(P>0.05)。在术后1年复发率上,康复新组和香菊组比较,差异无统计学意义(P>0.05)。随着治疗时间的延长,三组主观症状VAS评分均逐渐降低(P<0.05)。康复新组和香菊组术后4、12周时主观症状VAS评分均显著低于对照组同期(P<0.05),且与香菊组同时点对比,康复新组术后4、12周时主观症状VAS评分均显著更低(P<0.05)。康复新组术后8周时术腔黏膜上皮化比率达65.6%(19/29),均显著高于香菊组及对照组同期［40.0%(12/30)、26.7%(8/30),P<0.05］。康复新组和香菊组术腔黏膜上皮化时间较对照组均显著缩短(P<0.05),且康复新组较香菊组对缩短术腔黏膜上皮化时间更有利(P<0.05)。随着治疗时间的延长,三组鼻内镜Lund-Kennedy评分均逐渐下降(P<0.05)。康复新组和香菊组术后8周时鼻内镜Lund-Kennedy评分较对照组同期均显著更低(P<0.05),且康复新组术后8周时鼻内镜Lund-Kennedy评分显著低于香菊组同时点(P<0.05)。康复新组和香菊组术后3、7、15 d时血清hs-CRP、TNF-α和IL-6含量均显著低于对照组同期(P<0.05),血清IL-10含量则较对照组同时点均显著更高(P<0.05);且康复新组术后3、7、15 d时以上血清炎症因子水平的改善效果均显著优于香菊组同期(P<0.05)。90例患者均无明显药物相关副作用发生。结论与加用香菊胶囊口服治疗相比,FESS术后在布地奈德鼻喷雾剂喷鼻治疗基础上加用康复新液冲洗术腔治疗在整体疗效、控制复发及安全性方面的优势均显著且相近,但加用康复新液冲洗更能快速减轻CRSwNP患者术后主观临床症状,加速术腔黏膜向良性方向转归,进一步缩短术腔黏膜上皮化时间,其作用机制可能是通过迅速纠正体内炎症因子失衡的途径来实现的。“布地奈德鼻喷雾剂喷鼻+康复新液冲洗术腔”有望成为FESS术后的标准治疗方案之一。

关键词: 慢性鼻窦炎伴有鼻息肉, 功能性鼻内镜手术, 香菊胶囊, 康复新液, 术腔黏膜转归, 炎症因子

Abstract: Objective In order to evaluate the efficacy and safety of orally administered Xiangju Capsule and lavage with the Kangfuxin solution in patients with chronic rhinosinusitis with nasal polyps(CRSwNP)after functional endoscopic sinus surgery(FESS). Methods From January to December 2019, 90 patients with CRSwNP were randomly divided into three groups: rehabilitation (n=30), Xiangju(n=30), and control (n=30). All patients underwent FESS and the same routine postoperative management. After FESS, the control, Xiangju, and Kangfuxin groups were treated with budesonide nasal spray, Xiangju capsule, and Kangfuxin solution, respectively. The course of treatment was 12 weeks. The clinical effects, postoperative mucosal outcome, adverse reactions, and recurrence were compared among the three groups. The visual analogue scale(VAS)score of subjective symptoms and levels of high-sensitivity C-reactive protein(hs-CRP), tumor necrosis factors, and interleukin(IL)-6 and IL-10 were measured before and after the operation. Results There was no significant difference in the total effective rate in 96.7%(29/30)of the rehabilitation group, 93.3%(28/30)of the Xiangju group, and 86.7%(26/30)of the control group(P>0.05). Compared to the Xiangju group, there was no significant difference in the recurrence rate 1 year postoperatively in the group(P>0.05). As the treatment time prolonged, the VAS scores of subjective symptoms in all three groups gradually decreased(P<0.05). Four and 12 weeks postoperatively, the subjective symptom scores were significantly lower in the rehabilitation and Xiangju groups than in the control group(P<0.05)and in the rehabilitation group compared to the Xiangju group(P< 0.05). Eight weeks postoperatively, the epithelialization rate was 65.5%(19/29)in the Kangfuxin group, which was significantly higher than that in the Xiangju or control group(40.0% ［12/30］; 26.7% ［8/30］, P<0.05). Compared to the control group, the time of Mucosal epithelization in Kangfuxin group and Xiangju group was significantly shorter (P<0.05), and the time of mucosal epithelization in the Kangfuxin group was more favorable than that in the Xiangju group(P<0.05). The Lund-Kennedy score in all three groups decreased gradually with the treatment time(P<0.05). At the same time point, the Lund-Kennedy score in the rehabilitation and Xiangju groups were significantly lower than those in the control group(P<0.05)and in the rehabilitation group compared to the Xiangju group(P<0.05). The levels of serum hs-CRP, TNF, and IL-6 were significantly lower in the Kangfuxin and Xiangju groups than in the control group(P<0.05), and the levels of serum IL-10 were significantly higher in the Kangfuxin and Xiangju groups than in the control group(P<0.05). After 3, 7, and 15 days, the improvement in serum inflammatory factors in the rehabilitation group was significantly better than that in the Xiangju group(P<0.05). There were no significant drug-related side effects in any patient. Conclusion Compared to the treatment with the oral Xiangju capsule, the overall efficacy, recurrence control, and safety of post-FESS nasal spray combined with budesonide nasal spray and Kangfuxin irrigation were similar. However, the clinical symptoms of patients with CRSwNP can be quickly alleviated using the Kangfuxin solution, which can speed up the improvement of the mucosa and further shorten the time of mucosal epithelization. The mechanism of action may be the rapid correction of the imbalance of inflammatory factors in the body. “Budesonide nasal spray plus rehabilitation fluid irrigation cavity” is expected to become a standard treatment after FESS.

Key words: Chronic rhinosinusitis with nasal polyps, Functional endoscopic sinus surgery, Xiangju capsule, Kangfuxin solution, Mucosal outcome, Inflammatory factors

中图分类号:

R765.21

张金庄,殷璞,刘宁,王江宇,贾云芬,丁元吉,吴垚. FESS术后加用香菊胶囊与康复新液治疗慢性鼻窦炎伴有鼻息肉的对比研究[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 69-76.

ZHANG Jinzhuang, YIN Pu, LIU Ning, WANG Jiangyu, JIA Yunfen, DING Yuanji, WU Yao. Comparative study of the Xiangju capsule and Kangfuxin liquid in the treatment of chronic rhinosinusitis with nasal polyps after functional endoscopic sinus surgery[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 69-76.

参考文献

[1] Shi JB, Fu QL, Zhang H, et al. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities[J]. Allergy, 2015, 70(5): 533-539. doi:10.1111/all.12577.
[2] Kim JY, Kim DK, Yu MS, et al. Role of epigenetics in the pathogenesis of chronic rhinosinusitis with nasal polyps[J]. Mol Med Rep, 2018, 17(1):1219-1227. doi:10.3892/mmr.2017.8001.
[3] Kilty SJ, Lasso A, Mfuna-Endam L, et al. Case-control study of endoscopic polypectomy in clinic(EPIC)versus endoscopic sinus surgery for chronic rhinosinusitis with polyps[J]. Rhinology, 2018, 56(2):155-157. doi:10.4193/Rhin17.115.
[4] Levine CG, Casiano RR. Revision functional endoscopic sinus surgery[J]. Otolaryngol Clin North Am, 2017, 50(1): 143-164. doi:10.1016/j.otc.2016.08.012.
[5] Huang ZZ, Chen XZ, Huang JC, et al. Budesonide nasal irrigation improved Lund–Kennedy endoscopic score of chronic rhinosinusitis patients after endoscopic sinus surgery[J]. Eur Arch Otorhinolaryngol, 2019, 276(5): 1397-1403. doi:10.1007/s00405-019-05327-6.
[6] 张健, 王丽华, 沙志荣, 等. 通窍冲洗方对慢性鼻-鼻窦炎Fess术后恢复的疗效观察[J]. 中国中西医结合耳鼻咽喉科杂志, 2018, 26(5): 372-375. doi: CNKI:SUN:XYJH.0.2018-05-014.
[7] 刘宪宾. 香菊胶囊辅助治疗慢性鼻窦炎鼻息肉49例疗效观察[J]. 北方药学, 2017, 14(2): 58-59. doi: 10.3969/j.issn.1672-8351.2017.02.050.
[8] 宫文晶, 李敏. 鼻内镜术后康复新稀释液冲洗鼻腔配合布地奈德喷鼻剂的疗效观察[J]. 四川医学, 2013, 34(9): 1419-1420. doi: CNKI:SUN:SCYX.0.2013-09-075.
[9] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组. 慢性鼻-鼻窦炎诊断和治疗指南(2012年,昆明)[J]. 中华耳鼻咽喉头颈外科杂志, 2013, 48(2):92-94. doi: 10.3760/cma.j.issn.1673-0860.2013.02.002.
[10] 许庚, 李源, 谢民强, 等. 功能性内窥镜鼻窦手术后术腔黏膜转归阶段的划分及处理原则[J]. 中华耳鼻咽喉科杂志, 1999(5): 302-305. doi: 10.3760/j.issn:1673-0860.1999.05.018. XU Geng, LI Yuan, XIE Minqiang, et al. Staging of mucous membrane outcome in operative cavity after functional endoscopic sinus surgery[J]. Chinese Journal of Otorhinolaryngology, 1999(5): 302-305. doi: 10.3760/j.issn:1673-0860.1999.05.018.
[11] Lund V, Kennedy D. Staging for rhinosinusitis[J]. Otolaryngol-Head Neck Surg, 1997, 117(3): S35-S40. doi:10.1016/s0194-5998(97)70005-6.
[12] 胡守亮, 李辉, 朱天民, 等. 慢性鼻-鼻窦炎的病因及发病机制研究进展[J]. 实用医学杂志, 2019, 35(11):1846-1849. doi:10.3969/j.issn.1006-5725.2019.11.033.
[13] Kohanski MA, Workman AD, Patel NN, et al. Solitary chemosensory cells are a primary epithelial source of interleukin-25 in chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2018, 142(2):460-469. doi:10.1016/j.jaci.2018.03.019.
[14] Cao PP, Li HB, Wang BF, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese[J]. J Allergy Clin Immunol, 2009, 124(3):478-484. doi: 10.1016/j.jaci.2009.05.017.
[15] Leonard S, Sinha A, Reiter A, et al. Evaluation and stability analysis of video-based navigation system for functional endoscopic sinus surgery on in vivo clinical data[J]. IEEE Trans Med Imaging, 2018, 37(10): 2185-2195. doi:10.1109/TMI.2018.2833868.
[16] 余滋中, 付艳乔, 李国义. 鼻内镜术后糖皮质激素浸润对慢性鼻-鼻窦炎伴鼻息肉患者近期疗效及嗅觉功能的影响[J]. 基因组学与应用生物学, 2017, 36(7): 2722-2727. doi: 10.13417/j.gab.036.002722. YU Zizhong, FU Yanqiao, LI Guoyi. Effect of glucocorticoid infiltration on the short-term curative effect and olfactory functions of patients with chronic rhinosinusitis and nasal polyps[J]. Genomics and Applied Biology, 2017, 36(7): 2722-2727. doi: 10.13417/j.gab.036.002722.
[17] 尚规化, 蔡继红. 香菊胶囊联合桉柠蒎肠溶软胶囊治疗慢性鼻窦炎的临床研究[J]. 现代药物与临床, 2018, 33(12): 3326-3330. doi: 10.7501/j.issn.1674-5515.2018.12.054. SHANG Guihua, CAI Jihong. Clinical study on xiangju capsules combined with limonene and pinene enteric soft capsules in treatment of chronic sinusitis[J]. Drugs & Clinic, 2018, 33(12): 3326-3330. doi: 10.7501/j.issn.1674-5515.2018.12.054.
[18] 王洪锋, 翁柏岳. 香菊胶囊辅助治疗对慢性鼻窦炎鼻息肉患者鼻内镜术后的影响[J]. 辽宁中医杂志, 2013, 40(11): 2261-2262.
[19] 吕娜, 李广志, 王钧篪, 等. 美洲大蠊化学成分及生物活性的研究进展[J]. 现代生物医学进展, 2017, 17(16): 3184-3190. doi: 10.13241/j.cnki.pmb.2017.16.046. LV Na, LI Guangzhi, WANG Junchi, et al. Chemical components and biological activities in Periplaneta America[J]. Progress in Modern Biomedicine, 2017, 17(16): 3184-3190. doi: 10.13241/j.cnki.pmb.2017.16.046.
[20] 苏金霏, 王振霖, 丁秀勇, 等. 康复新液在FESS术后冲洗的临床研究[J]. 中国中西医结合耳鼻咽喉科杂志, 2018, 26(4): 261-263. doi: 10.16542/j.cnki.issn.1007-4856.2018.04.006. SU Jinfei, WANG Zhenlin, DING Xiuyong, et al. Clinical study of Kangfuxin Ye irrigation after functional endoscopic sinus surgery[J]. Chinese Journal of Otorhinolaryngology In Integrative Medicine, 2018, 26(4): 261-263. doi: 10.16542/j.cnki.issn.1007-4856.2018.04.006.
[21] 于玺泓. 鼻窦方冲洗联合穴位针刺对慢性鼻窦炎鼻内镜术后患者鼻黏膜功能形态恢复及相关炎性指标的影响[J]. 现代中西医结合杂志, 2020, 29(6): 606-609. doi: 10.3969/j.issn.1008-8849-2020.06.009. YU Xihong. Effects of nasal sinus decoction combined with acupuncture on recovery of nasal mucosal function and morphology,related inflammatory indexes in patients with chronic sinusitis after endoscopic sinus surgery[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2020, 29(6): 606-609. doi: 10.3969/j.issn.1008-8849-2020.06.009.
[22] Wu J, Chandra RK, Li P, et al. Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis[J]. Laryngoscope, 2018, 128(9): E304-E310. doi:10.1002/lary.27112.
[23] Shin SH, Ye MK, Choi SY, et al. Anti-inflammatory effect of bee venom in an allergic chronic rhinosinusitis mouse model[J]. Mol Med Rep, 2018, 17(5): 6632-6638. doi:10.3892/mmr.2018.8720.
[24] 徐林弟, 陈寻, 刘晴. 鼻内镜治疗真菌性鼻-鼻窦炎的疗效及对患者免疫功能和炎性因子的影响[J]. 中国中西医结合耳鼻咽喉科杂志, 2018, 26(2): 95-98. doi: 10.16542/j.cnki.issn.1007-4856.2018.02.005. XU Lindi, CHEN Xun, LIU Qing. The clinical efficacy of nasal endoscopic treatment for patients with fungal rhinosinusitis and its effect on immune function and inflammatory factor[J]. Chinese Journal of Otorhinolaryngology In Integrative Medicine, 2018, 26(2): 95-98. doi: 10.16542/j.cnki.issn.1007-4856.2018.02.005.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed